Investigación / Grupos de investigación

Grupo  402

Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Publicaciones (399)

  • Salguero, S; Medrano, LM; Gonzalez-Garcia, J; Berenguer, J; Montes, ML; Diez, C; Garcia-Broncano, P; Llop-Herrera, E; Perez-Latorre, L; Bellono, JM; Jimenez-Sousa, MA; Resino, S.

    Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study

    Scientific Reports. 2020; 10(1): Nº de citas: 7 [doi:10.1038/s41598-020-67159-3]

  • Trickey, A; May, MT; Gill, MJ; Grabar, S; Vehreschild, J; Wit, FWNM; Bonnet, F; Cavassini, M; Abgrall, S; Berenguer, J; Wyen, C; Reiss, P; Grabmeier-Pfistershammer, K; Guest, JL; Shepherd, L; Teira, R; Monforte, AD; del Amo, J; Justice, A; Costagliola, D; Sterne, JAC.

    Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies

    INTERNATIONAL JOURNAL OF CANCER. 2020; 146(11): 3134-3146 Nº de citas: 23 [doi:10.1002/ijc.32895]

  • Alvaro-Meca, A; Mate-Cano, I; Ryan, P; Briz, V; Resino, S.

    Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000-2015): A Nationwide Study

    Journal of Clinical Medicine. 2020; 9(6): Nº de citas: 4 [doi:10.3390/jcm9061607]

  • Mate-Cano, I; Alvaro-Meca, A; Ryan, P; Resino, S; Briz, V.

    Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study

    European Journal of Internal Medicine. 2020; 75: 84-92 Nº de citas: 9 [doi:10.1016/j.ejim.2020.02.002]

  • Casado, JL; Vizcarra, P; Blanco, JL; Montejano, R; Negredo, E; Espinosa, N; Montero, M; Mena, A; Palacios, R; Lopez, JC; Vergas, J; Galindo, MJ; Cabello, A; Deltoro, MG; De Santiago, AD.

    Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

    INTERNATIONAL JOURNAL OF STD & AIDS. 2020; 31(5): 467-473 Nº de citas: 4 [doi:10.1177/0956462419896478]

  • Valencia, J; Alvaro-Meca, A; Troya, J; Gutierrez, J; Ramon, C; Rodriguez, A; Vazquez-Moron, S; Resino, S; Moreno, S; Ryan, P.

    Gender-based vulnerability in women who inject drugs in a harm reduction setting

    PLoS One. 2020; 15(3): Nº de citas: 39 [doi:10.1371/journal.pone.0230886]

  • Alvarez, S; Branas, F; Sanchez-Conde, M; Moreno, S; de Quiros, JCLB; Munoz-Fernandez, MA.

    Frailty, markers of immune activation and oxidative stress in HIV infected elderly

    PLoS One. 2020; 15(3): Nº de citas: 30 [doi:10.1371/journal.pone.0230339]

  • Vizcarra, P; Blanco, JL; Montejano, R; Negredo, E; Espinosa, N; Casado, JL; Monsalvo, M; Blanco, JL; Bernardino, JI; Puig, J; Montero, M; Castro, I; Mena, A; Castro, A; Palacios, R; de Quiros, JCLB; Tejerina, F; Latorre, LP; Ramirez, M; Vergas, J; Tellez, MJ; Galindo, P; Vilalta, RF; Cabello, A; Deltoro, MG; Cuevas, PR; de Santiago, AD; Moral, SD.

    Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

    Infectious Diseases. 2020; 52(3): 202-206 Nº de citas: 3 [doi:10.1080/23744235.2019.1694696]

  • Carrero, A; Berenguer, J; Hontanon, V; Navarro, J; Hernandez-Quero, J; Galindo, MJ; Quereda, C; Santos, I; Tellez, MJ; Ortega, E; Sanz, J; Medrano, LM; Perez-Latorre, L; Bellon, JM; Resino, S; Bermejo, J; Gonzalez-Garcia, J.

    Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2020; 83(3): 292-300 Nº de citas: 7 [doi:10.1097/QAI.0000000000002260]

  • Hernandez-Walias, FJ; Vazquez, E; Pacheco, Y; Rodriguez-Fernandez, JM; Perez-Elias, MJ; Dronda, F; Casado, JL; Moreno, A; Hermida, JM; Quereda, C; Hernando, A; Tejerina-Picado, F; Asensi, V; Galindo, MJ; Leal, M; Moreno, S; Vallejo, A.

    Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

    Journal of Clinical Medicine. 2020; 9(3): Nº de citas: 15 [doi:10.3390/jcm9030760]

  • Garcia-Broncano, P; Medrano, LM; Berenguer, J; Brochado-Kith, O; Gonzalez-Garcia, J; Jimenez-Sousa, A; Quereda, C; Sanz, J; Tellez, MJ; Diaz, L; JImenez, JL; Resino, S; Carrero, A; Miralles, P; Lopez, JC; Parras, F; Padilla, B; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Perez-Latorre, L; Fanciulli, C; Gutierrez, I; Ramirez, M; Carretero, S; Bellon, JM; Bermejo, J; Berenguer, J; Hontanon, V; Arribas, JR; Montes, ML; Bernardino, I; Pascual, JF; Zamora, F; Pena, JM; Arnalich, F; Diaz, M; Gonzalez-Garcia, J; Domingo, P; Guardiola, JM; Van den Eynde, E; Perez, M; Ribera, E; Crespo, M; Casado, JL; Dronda, F; Moreno, A; Perez-Elias, MJ; Sanfrutos, MA; Moreno, S; Quereda, C; Arranz, A; Casas, E; de Miguel, J; Schroeder, S; Sanz, J; Santos, I; Bustinduy, MJ; Iribarren, JA; Rodriguez-Arrondo, F; Von-Wichmann, MA; Vergas, J; Tellez, MJ; Vinuesa, D; Munoz, L; Hernandez-Quero, J; Ferrer, A; Galindo, MJ; Ortiz, L; Ortega, E; Montero, M; Blanes, M; Cuellar, S; Lacniz, J; Salavert, M; Lopez-Aldeguer, J; Perez, G; Gaspar, G; Yllescas, M; Crespo, P; Aznar, E; Esteban, H; GESIDA 3603b Study Grp.

    Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study

    JOURNAL OF INFECTION. 2020; 80(1): 99-110 Nº de citas: 13 [doi:10.1016/j.jinf.2019.09.020]

  • Trickey, A; van Sighem, A; Stover, J; Abgrall, S; Grabar, S; Bonnet, F; Berenguer, J; Wyen, C; Casabona, J; Monforte, AD; Cavassini, M; del Amo, J; Zangerle, R; Gill, MJ; Obel, N; Sterne, JAC; May, MT.

    Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings

    AIDS. 2019; 33: 271-281 Nº de citas: 8 [doi:10.1097/QAD.0000000000002387]

  • Dolengevich-Segal, H; Gonzalez-Baeza, A; Valencia, J; Valencia-Ortega, E; Cabello, A; Tellez-Molina, MJ; Perez-Elias, MJ; Serrano, R; Perez-Latorre, L; Martin-Carbonero, L; Arponen, S; Sanz-Moreno, J; De la Fuente, S; Bisbal, O; Santos, I; Casado, JL; Troya, J; Cervero-Jimenez, M; Nistal, S; Cuevas, G; Correas-Lauffer, J; Torrens, M; Ryan, P; U-SEX GESIDA 9416 Study.

    Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study

    PLoS One. 2019; 14(12): Nº de citas: 45 [doi:10.1371/journal.pone.0220272]

  • Couto, E; Diaz-Brito, V; Mothe, B; Guardo, AC; Fernandez, I; Ugarte, A; Etcheverry, F; Gomez, CE; Esteban, M; Pich, J; Arnaiz, JA; de Quiros, JCLB; Brander, C; Plana, M; Garcia, F; Leal, L.

    Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

    Vaccines. 2019; 7(4): Nº de citas: 1 [doi:10.3390/vaccines7040178]

  • Feher, C; Leal, L; Plana, M; Climent, N; Guardo, AC; Martinez, E; Castro, P; Diaz-Brito, V; Mothe, B; De Quiros, JCLB; Gatell, JM; Aloy, P; Garcia, F.

    Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients

    Open Forum Infectious Diseases. 2019; 6(12): Nº de citas: 8 [doi:10.1093/ofid/ofz485]

  • Fernandez-Ruiz, M; Cardozo, C; Salavert, M; Aguilar-Guisado, M; Escola-Verge, L; Munoz, P; Gioia, F; Montejo, M; Merino, P; Cuervo, G; Garcia-Vidal, C; Aguado, JM; Padilla, B; Pano-Pardo, JR; Garcia-Rodriguez, J; Cerrada, CG; Ryan, P; Campelo, C; Gil, ID; Buendia, V; Gorricho, BP; Alonso, M; Sanz, FS; Romo, FG; Gorgolas, M; Gadea, I; Losa, JE; Delgado-Iribarren, A; Ramos, A; Romero, Y; Romero, IS; Zaragoza, O; Cuenca-Estrella, M; Rodriguez-Bano, J; Suarez, AI; Loza, A; Garcia, AIA; Martin-Mazuelos, E; de Pipaon, MRP; Garnacho, J; Ortiz, C; Chavez, M; Maroto, FL; Peman, J; Blanquer, J; Camarena, JJ; Zaragoza, R; Abril, V; Gimeno, C; Hernandez, S; Ezpeleta, G; Bereciartua, E; Almaraz, JLH; Rivas, RA; Ayarza, R; Planes, AM; Ruiz-Camps, I; Mensa, J; Almela, M; Gurgui, M; Sanchez-Reus, F; Martinez-Montauti, J; Sierra, M; Horcajada, JP; Sorli, L; Gomez, J; Gene, A; Urrea, M; Diaz-Martin, A; Puchades, F; Mularoni, A; Puerta-Alcalde, P; Morata, L; Rodriguez-Nunez, O; Guerrero, MA; Carratala, J; Sabe, N; Ayats, J; Grau, I; Calabuig, E; Castro, I; Cuellar, S; Fortun, J; Martin-Davila, P; de la Pedrosa, EGG; Perez-Ayala, A; Losada, I; Navarro, D; Suarez, MI; Martin-Gomez, MT; Almirante, B; Rodriguez-Alvarez, R; Lopez-Soira, L; Vena, A; Valerio, M; Bouza, E; Guinea, J; Martin, C; CANDIPOP Project; CANDI Bundle Grp; GEIRAS GEMICOMED SEIMC REIPI.

    Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome

    Transplant Infectious Disease. 2019; 21(6): Nº de citas: 22 [doi:10.1111/tid.13195]

  • Requena, S; Caballero, E; Lozano, AB; Rios-Villegas, MJ; Benito, R; Rojo, S; Cabezas, T; Macia, MD; Nieto, MD; Soriano, V; de Mendoza, C; Rodriguez, C; Vera, M; del Romero, J; Ocete, MD; Caballero, E; Aguilera, A; Amengual, MJ; Cervantes, M; Benito, R; Algarate, S; de Lejarazu, RO; Rojo, S; Eiros, JM; Ramos, C; Garcia-Costa, J; Calderon, E; Rios-Villegas, MJ; Trigo, M; Diz, J; Garcia-Campello, M; Rodriguez-Iglesias, M; Hernandez-Betancor, A; Ramos, JM; Gimeno, A; Sanchez, V; Gomez-Hernando, C; Echeverria, MJ; Cilla, G; Perez-Trallero, E; Fernandez-Pereira, L; Niubo, J; Margall, N; Hernandez, M; Lopez-Lirola, AM; Gomez-Sirvent, JL; Force, L; Sauca, M; Perez, S; Morano, L; Raya, C; Praetorius, AG; Cifuentes, C; Penaranda, M; Nieto, MC; Montejo, JM; Roc, L; Martinez-Sapina, A; Viciana, I; Lozano, AB; Perez-Camacho, I; Fernandez-Fuertes, E; Fernandez, JM; Cabezas, T; Bermejo, IG; Gaspar, G; Gorgolas, M; Vegas, C; Blas, J; Tellez, R; Perez, L; Valeiro, M; Aldamiz, T; Garcia, F; Suarez, A; Rodriguez-Avial, I; Barreiro, P; Soriano, V; Gomez-Gallego, F; Corral, O; Requena, S; Benitez-Gutierrez, L; Cuervas-Mons, V; de Mendoza, C.

    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

    AIDS. 2019; 33(14): 2167-2172 Nº de citas: 13 [doi:10.1097/QAD.0000000000002338]

  • Perez, AB; Chueca, N; Garcia-Deltoro, M; Martinez-Sapina, AM; Lara-Perez, MM; Garcia-Bujalance, S; Aldamiz-Echevarria, T; Vera-Mendez, FJ; Pineda, JA; Casado, M; Pascasio, JM; Salmeron, J; Alados-Arboledas, JC; Poyato, A; Tellez, F; Rivero-Juarez, A; Merino, D; Vivancos-Gallego, MJ; Rosales-Zabal, JM; Garcia, F; Ocete, MD; Simon, MA; Rincon, P; Reus, S; De la Iglesia, A; Garcia-Arata, I; Jimenez, M; Jimenez, F; Hernandez-Quero, J; Galera, C; Balghata, MO; Primo, J; Masia, M; Espinosa, N; Delgado, M; von-Wichmann, MA; Collado, A; Santos, J; Minguez, C; Diaz-Flores, F; Fernandez, E; Bernal, E; De Juan, J; Anton, JJ; Velez, M; Aguilera, A; Navarro, D; Arenas, JI; Fernandez, C; Espinosa, MD; Rios, MJ; Alonso, R; Hidalgo, C; Hernandez, R; Tellez, MJ; Rodriguez, FJ; Antequera, P; Delgado, C; Martin, P; Crespo, J; Becerril, B; Perez, O; Garcia-Herola, A; Montero, J; Freyre, C; Grau, C.

    High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world

    JOURNAL OF HEPATOLOGY. 2019; 71(5): 876-888 Nº de citas: 13 [doi:10.1016/j.jhep.2019.06.022]